HEPA

Hepion Pharmaceuticals
HEPA

Delisted

HEPA was delisted on the 12th of May, 2025.

Back to rankings

15 hedge funds and large institutions have $4M invested in Hepion Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$21K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.98M
2
+$10.9K
3
+$9.8K

Top Sellers

1
-$437K
2
-$140K
3
-$51.1K
4
UBS Group
UBS Group
Switzerland
-$28K
5
BlackRock
BlackRock
New York
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.98M
2
$826K
3
$414K
4
$337K
5
$174K
6
$78.2K
7
$73K
8
$65.3K
9
$22.4K
10
$14.4K
11
$11.1K
12
$1.69K
13
$873
14
$140
15
$25
16
$10
17
$5
18
$5
19
$5
20
$5
21
$5
22
–